脂肪性肝炎
酶
肝酶
作文(语言)
内科学
非酒精性脂肪性肝炎
医学
生物化学
化学
脂肪肝
生物
内分泌学
疾病
语言学
哲学
非酒精性脂肪肝
作者
Tzu Keng Shen,Thibaut Vignane,Eduardo Hideo Gilglioni,Leonardo Traini,Elisavet Kalaitsidou,Pierre Conan,Ao Li,Wadsen St‐Pierre‐Wijckmans,José M. Herranz,Bernat Elvira,Lukas Otero Sanchez,Eric Trépo,Leo Deelman,Wei Wu,Miloš R. Filipović,Joris Messens,Daria Ezeriņa,Esteban N. Gurzov
出处
期刊:Redox biology
[Elsevier BV]
日期:2025-08-05
卷期号:86: 103809-103809
被引量:9
标识
DOI:10.1016/j.redox.2025.103809
摘要
Metabolic dysfunction–associated steatohepatitis (MASH) is a progressive disease driven by obesity-related hepatic inflammation and oxidative stress. Recently, cysteine persulfidation (PSSH), a protective post-translational modification by hydrogen sulfide (H 2 S), was established to play a role in redox regulation. Despite the role of the liver in H 2 S metabolism, the function of PSSH in MASH remains underexplored. We demonstrated that H 2 S-producing enzymes are downregulated in both human and mouse livers with steatosis and fibrosis, resulting in a decline in global PSSH levels. Surprisingly, dimedone-switch mass spectrometry in dietary mouse models of distinct obesity-associated liver disease stages revealed dysregulated PSSH on specific proteins. In particular, increased hepatic PSSH levels of protein tyrosine phosphatases and redox regulators were found in advanced disease stages, suggesting a targeted adaptive response to oxidative stress. Overall, our findings demonstrated that impaired H 2 S production disrupts protective PSSH networks in MASH. However, selective PSSH preservation on redox-sensitive proteins may represent a compensatory mechanism, underscoring the therapeutic potential of persulfidation in restoring redox homeostasis during obesity-associated chronic liver disease.
科研通智能强力驱动
Strongly Powered by AbleSci AI